0 NYSE Companies - May 7, 2024Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results– Reported topline data from the investigator sponsored Phase 1 trial of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma; […]Read More
0 NYSE Companies - May 7, 2024Solaris Provides Update on Warintza Operations, Optimization Progress, and Appointment of Leading Consultants for the EIA and PFSVANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) […]Read More
0 NYSE Companies - May 7, 2024American Shared Hospital Services Announces First Quarter 2024 Earnings Conference CallSAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider […]Read More
0 NYSE Companies - May 7, 2024Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital PartnersWILMINGTON, Del., May 07, 2024 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive […]Read More
0 NYSE Companies - May 7, 2024Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company […]Read More
0 NYSE Companies - May 7, 2024Reliance, Inc. Announces Upcoming Conference ParticipationSCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE: RS) announced today that its management team will participate […]Read More
0 NYSE Companies - May 7, 2024TopBuild Reports First Quarter Results, Raises 2024 Outlook and Announces $1B Share Repurchase AuthorizationFirst quarter sales grow 1.1% to $1.3 billion Gross margin expands 100 basis points to 30.3% Adjusted EBITDA margin expands […]Read More
0 NYSE Companies - May 7, 2024Robust Mix Sustained a Strong Start to the YearRobust Mix Sustained a Strong Start to the Year Net revenues of Euro 1,585 million, up 10.9% versus prior year, […]Read More
0 NYSE Companies - May 7, 2024Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPHWAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced […]Read More
0 NYSE Companies - May 7, 2024Costamare Inc. Sets the Date for Its First Quarter 2024 Results Release, Conference Call and WebcastEarnings Release: Friday, May 10, 2024, Before Market OpensConference Call and Webcast: Friday, May 10, 2024, at 8:30 a.m. ET […]Read More